NBP615
/ SK Bio
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 01, 2020
Immunogenicity and Safety Study of NBP615 in Healthy Female
(clinicaltrials.gov)
- P1/2; N=200; Completed; Sponsor: SK Bioscience Co., Ltd.
Clinical • New P1/2 trial • Cervical Cancer • Gynecologic Cancers • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1